Minerva Neurosciences NERV
NASDAQ NERV
$2.53 +0.21 (+9.05%)
At close: Oct 20, 2026 · 4:00 PM EDT

Minerva Neurosciences (NERV) EV to EBITDA (2020 - 2023)

Updated

Minerva Neurosciences' (NERV) EV to EBITDA was 6.69 for Q1 2021, down 83.3% from the prior quarter.

Analysis

Minerva Neurosciences (NERV) EV to EBITDA (2020 - 2023) Analysis & Trends

Over the twelve months ended Mar 31, 2021, Minerva Neurosciences' EV to EBITDA came in at -7.28; for FY2020, it was 40.05.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 Minerva Neurosciences 117.90 Mn -130.03 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 -3.08
Dec 31, 2020 36.87
API Access

Minerva Neurosciences EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=NERV&period=max&api_key=YOUR_API_KEY